NCT06172296 2026-04-14Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaNational Cancer Institute (NCI)Phase 3 Recruiting478 enrolled